Northeast Financial Consultants Inc Merck & Co., Inc. Transaction History

Northeast Financial Consultants Inc

$2.02 Billion
Q1 2024

A detailed history of Northeast Financial Consultants Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 76,646 shares of MRK stock, worth $9.49 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

76,646

Previous 75,561 1.44%

Holding current value

$9.49 Million

Previous $8.24 Million 22.78%

% of portfolio

0.5%

Previous 0.46%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $122,865 - $143,165	1,085 Added 1.44%	76,646 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $9,216 - $10,029	92 Added 0.12%	75,561 $8.24 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $35,003 - $38,872	340 Added 0.45%	75,469 $7.77 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $8,797 - $9,588	81 Added 0.11%	75,129 $8.67 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $8,544 - $9,533	83 Added 0.11%	75,048 $7.98 Million

Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $93,211 - $119,509	-1,066 Reduced 1.4%	74,965 $8.32 Million
Q3 2022 Nov 15, 2022	BUY	$84.53 - $94.96 $66,863 - $75,113	791 Added 1.05%	76,031 $6.55 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $183,344 - $207,829	-2,196 Reduced 2.84%	75,240 $6.86 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $176,276 - $197,595	2,398 Added 3.2%	77,436 $6.35 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $83,266 - $104,302	-1,152 Reduced 1.51%	75,038 $5.75 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $2.85 Million - $3.14 Million	-39,800 Reduced 34.31%	76,190 $5.72 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $38,811 - $42,929	552 Added 0.48%	115,990 $9.02 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $43,932 - $51,748	-638 Reduced 0.55%	115,438 $8.9 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $46,076 - $51,135	642 Added 0.56%	116,076 $9.5 Million
Q3 2020 Oct 29, 2020	BUY	$73.18 - $82.95 $24,149 - $27,373	330 Added 0.29%	115,434 $9.58 Million
Q2 2020 Jul 30, 2020	BUY	$70.42 - $80.13 $6,126 - $6,971	87 Added 0.08%	115,104 $8.9 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $4,942 - $6,849	78 Added 0.07%	115,017 $8.85 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $120,171 - $135,599	-1,549 Reduced 1.33%	114,939 $10.5 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $95,480 - $104,077	1,255 Added 1.09%	116,488 $9.81 Million
Q2 2019 Aug 09, 2019	BUY	$69.84 - $81.59 $5,307 - $6,200	76 Added 0.07%	115,233 $9.66 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $35,416 - $40,394	-509 Reduced 0.44%	115,157 $9.58 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $7.35 Million - $8.53 Million	112,657 Added 3744.0%	115,666 $8.84 Million
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $173,589 - $204,130	3,009 New	3,009 $213,000

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Merck & Co., Inc. Transaction History